FinanceHealth-ITNews

India Accelerator, Lyxel&Flamingo invest in Answer Genomics 

The startup will be operational in four different phases to realise the potential of AI and machine learning

Machine learning and genomics startup Answer Genomics has raised an undisclosed amount of funding from India Accelerator (IA) and Lyxel&Flamingo an independent digital media companies in India. Incepted in December 2018, the startup was a part of IA’s seed-stage accelerator programme – the only GAN partnered, a mentorship-driven programme in India.  

Answer Genomics, combines genomic, physiological and physical parameters to provide the most comprehensive picture of the present and future health. Answer Genomics predicts the occurrence, spread and treatment of lifestyle and clinical disorders by assaying genetic makers using their proprietary genomic and machine-learning systems.

The startup will be operational in four different phases to realise the potential of AI and machine learning. The startup is already through phase 1 and recently launched its first product #NGH-768’ under the brand name ‘NuGenomics’. It presents its patented nutrition recommendation system on a machine learning platform to make nutrition recommendations tailored to an individual!s DNA to help alleviate several lifestyle disorders. The company is currently tying up with organisations to offer its services to employees as well as to individuals who can register on the platform and get personalised nutrition and superfoods recommendations after detailed genetic diagnostics. 

Anjan Bose- Lead Mentor, Health-Tech vertical, IA said, “Genomics Research is crucial in providing a precise and personalised form of treatment for chronic lifestyle condition. We believe that our decision to mentor Answer Genomics has the potential to offer a revolutionary product to the market. The immense potential of such a startup to leverage new cutting-edge technologies should result in more accurate prediction of outcomes from health interventions to further ensure better treatment.” 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close